Stem (NYSE:STEM – Get Free Report) had its price target cut by analysts at Susquehanna from $7.50 to $4.50 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Susquehanna’s price objective suggests a potential upside of 12.33% from the stock’s current price.
Other analysts have also issued reports about the stock. Roth Capital reissued a “neutral” rating and issued a $6.75 price objective on shares of Stem in a research report on Monday, August 17th. Barclays decreased their price objective on shares of Stem from $18.00 to $8.00 and set an “equal weight” rating for the company in a research note on Monday, July 27th. New Street Research set a $8.00 target price on Stem in a research report on Monday, July 27th. UBS Group raised Stem from a “neutral” rating to a “buy” rating and set a $7.00 target price on the stock in a research note on Friday, September 25th. Finally, Wall Street Zen raised Stem from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 15th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $6.85.
Read Our Latest Research Report on Stem
Stem Trading Down 1.3%
Shares of STEM opened at $4.01 on Wednesday. Stem has a twelve month low of $3.70 and a twelve month high of $32.23. The company has a market cap of $38.58 million, a P/E ratio of -0.47 and a beta of 1.58. The company’s fifty day simple moving average is $5.07 and its 200-day simple moving average is $7.24.
Stem (NYSE:STEM – Get Free Report) last released its earnings results on Wednesday, August 12th. The company reported ($1.58) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.75) by $0.17. The firm had revenue of $33.65 million during the quarter, compared to the consensus estimate of $36.65 million. Analysts predict that Stem will post -7.04 earnings per share for the current fiscal year.
Institutional Trading of Stem
Institutional investors and hedge funds have recently made changes to their positions in the business. Engineers Gate Manager LP bought a new position in shares of Stem in the second quarter worth about $99,000. Royal Bank of Canada increased its stake in Stem by 8.8% in the 1st quarter. Royal Bank of Canada now owns 28,213 shares of the company’s stock worth $249,000 after buying an additional 2,275 shares during the period. Hsbc Holdings PLC increased its stake in Stem by 48.1% in the 4th quarter. Hsbc Holdings PLC now owns 28,424 shares of the company’s stock worth $434,000 after buying an additional 9,233 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in Stem by 423.0% during the 1st quarter. Renaissance Technologies LLC now owns 58,575 shares of the company’s stock valued at $518,000 after buying an additional 47,375 shares in the last quarter. 61.63% of the stock is currently owned by institutional investors.
Stem Company Profile
Stem, Inc is a clean-energy technology company that provides software and services for managing renewable energy and energy storage assets. Its platform is designed to help commercial, industrial and utility customers optimize electricity use, coordinate battery storage, and improve the performance of solar and other distributed energy resources.
The company’s offerings have included Athena, an artificial-intelligence-driven energy optimization platform, as well as software for monitoring, managing and reporting on renewable energy assets.
Recommended Stories
- Five stocks we like better than Stem
- PepsiCo’s Earnings Beat Masks a Bigger Problem With Its North American Business
- Tax Credit Turmoil: Why Enphase and SolarEdge Face a Tough Road
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
